These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 39123194)

  • 21. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance.
    Mao JX; Li JJ; Lu XY; Zhong HX; Zhao YY; Zhu LY; Fu H; Ding GS; Teng F; Chen M; Guo WY
    Int Immunopharmacol; 2024 Jul; 136():112340. PubMed ID: 38820962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
    Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
    Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma.
    Liang F; Liang H; Li Z; Huang P
    Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis.
    Tang W; Shao Q; He Z; Zhang X; Li X; Wu R
    BMC Cancer; 2023 Apr; 23(1):303. PubMed ID: 37013511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLC11A1 promotes kidney renal clear cell carcinoma (KIRC) progression by remodeling the tumor microenvironment.
    Wu D; Zhou Y; Shi X; Yi X; Sheng Z; Fan L; Ge J; Cheng W; Zhou W; He H; Fu D
    Toxicol Appl Pharmacol; 2024 Jun; 487():116975. PubMed ID: 38762191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and validation of a cigarette smoke-related five-gene signature as a prognostic biomarker in kidney renal clear cell carcinoma.
    Huang Y; Wang Q; Tang Y; Liu Z; Sun G; Lu Z; Chen Y
    Sci Rep; 2022 Feb; 12(1):2189. PubMed ID: 35140327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 34. Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy.
    Shan J; Xu Y; Lun Y
    Sci Rep; 2024 Sep; 14(1):22138. PubMed ID: 39333254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nc-RNA-mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma.
    Zeng X; Du S; Geng L; Ma J
    Cancer Med; 2024 Aug; 13(15):e70105. PubMed ID: 39140420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC).
    Du GW; Yan X; Chen Z; Zhang RJ; Tuoheti K; Bai XJ; Wu HH; Liu TZ
    Aging (Albany NY); 2020 May; 12(9):8484-8505. PubMed ID: 32406866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of proteomics and transcriptomics to construct a prognostic signature of renal clear cell carcinoma.
    Cheng G; Zhou Z; Li S; Ye Z; Wang Y; Wen J; Ren C
    Int J Med Sci; 2024; 21(11):2215-2232. PubMed ID: 39239554
    [No Abstract]   [Full Text] [Related]  

  • 40. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
    Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
    Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.